Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention John LittAnthony L. CunninghamRaunak Parikh Review Open access 04 June 2024
Opportunities to Enhance Diagnostic Testing and Antimicrobial Stewardship: A Qualitative Multinational Survey of Healthcare Professionals Timothy JinksSumithra SubramaniamClare Willis Original Research Open access 03 June 2024
Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir Francesca BaiTomaso BeringheliGiulia Marchetti Original Research Open access 03 June 2024
Ceftazidime-Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta-analysis Ryan K. ShieldsJuan P. HorcajadaTobias Welte Original Research Open access 31 May 2024
Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy Yasuhito TanakaDaisuke NakamotoHarriet Dickinson Original Research Open access 29 May 2024
Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-analysis Using GRADE Sushma KavikondalaKatrin HaeusslerNicolas Van de Velde Review Open access 27 May 2024
Lifetime Health and Economic Burden of Invasive Pneumococcal Diseases Attributable to V116 Serotypes Among Adults in the United States Zinan YiKelly D. JohnsonKwame Owusu-Edusei Original Research Open access 25 May 2024
Population Pharmacokinetics of Bepirovirsen in Healthy Participants and Participants with Chronic Hepatitis B Virus Infection: Results from Phase 1, 2a, and 2b Studies Amir S. YoussefMohamed IsmailAhmed Nader Original Research Open access 25 May 2024
Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir Genoveva CuestaJudit CachoMarta Bodro Brief Report Open access 24 May 2024
Responding to the Call to Action: Framework to Accelerate Clinical Data Generation for Antiretroviral Use in Pregnant Individuals with HIV Vani VannappagariScott McCallisterAnnemiek de Ruiter Commentary Open access 22 May 2024
A Phase 3, Randomized, Controlled Trial Evaluating the Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Moderate COVID-19 Wang-Da LiuPo-Hao FengWang-Huei Sheng Original Research Open access 21 May 2024
The Multifaceted Burden of Respiratory Syncytial Virus (RSV) Infections in Young Children on the Family: A European Study Ilona TrautmannsbergerBarbara Plaggthe ResQ Family study group Original Research Open access 20 May 2024
Molnupiravir Use Among Patients with COVID-19 in Real-World Settings: A Systematic Literature Review Julia Richmond DiBelloValerie T. RazianoDeanna D. Hill Review Open access 14 May 2024 Pages: 1177 - 1198
Clinical Characteristics and Fatality Risk Factors for Patients with Listeria monocytogenes Infection: A 12-Year Hospital-Based Study in Xi’an, China Wen XuMei-Juan PengYe Zhang Original Research Open access 11 May 2024 Pages: 1359 - 1378
Cost-effectiveness of PCV20 to Prevent Pneumococcal Disease in the Pediatric Population: A German Societal Perspective Analysis An TaFelicitas KühneJohnna Perdrizet Original Research Open access 11 May 2024 Pages: 1333 - 1358
Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain Javier Álvarez AldeanIrene Rivero CalleVirginia Lozano Original Research Open access 11 May 2024 Pages: 1315 - 1331
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups Samah HayekJoseph LevyAlon Peretz Brief Report Open access 10 May 2024 Pages: 1379 - 1389
Distribution of Nosocomial Pathogens and Antimicrobial Resistance among Patients with Burn Injuries in China: A Comprehensive Research Synopsis and Meta-Analysis Yuhui YangQingling ZengGaoming Li Original Research Open access 09 May 2024 Pages: 1291 - 1313
Clinical Outcomes of Integrase Strand Transfer Inhibitors Containing Antiretroviral Therapy in HIV-2: A Narrative Review Wendy J. BoschlooBerend J. van Welzen Review Open access 09 May 2024 Pages: 1161 - 1175
Penetration Profile of Terbinafine Compared to Amorolfine in Mycotic Human Toenails Quantified by Matrix-Assisted Laser Desorption Ionization–Fourier Transform Ion Cyclotron Resonance Imaging Nicolas Joly-TonettiRaphael LegouffeMartin Schaller Original Research Open access 07 May 2024 Pages: 1281 - 1290
Respiratory Syncytial Virus Sequelae Among Adults in High-Income Countries: A Systematic Literature Review and Meta-analysis Egbe UbamaduEstefania BetancurElizabeth Begier Review Open access 06 May 2024
Penetration Profiles of Four Topical Antifungals in Mycotic Human Toenails Quantified by Matrix-Assisted Laser Desorption Ionization–Fourier Transform Ion Cyclotron Resonance Imaging Nicolas Joly-TonettiRaphael LegouffeMartin Schaller Original Research Open access 04 May 2024 Pages: 1269 - 1279
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials Myron J. LevinAndrew UstianowskiMark T. Esser Original Research Open access 04 May 2024 Pages: 1253 - 1268
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults Lucila Rey-AresAhuva AverinLiping Huang Original Research Open access 03 May 2024 Pages: 1235 - 1251
Nasal Staphylococcus aureus Carriage and Antimicrobial Resistance Profiles Among Community-Dwelling Adults in Jiangsu, China Wenjing HuYang WangFengcai Zhu Original Research Open access 03 May 2024 Pages: 1215 - 1233
Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan Chun-Chi YangChung-Feng HuangMing-Lung Yu Original Research Open access 28 April 2024 Pages: 1199 - 1213
Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial Julie M. StrizkiJay A. GroblerCarisa De Anda Correction Open access 25 April 2024 Pages: 1159 - 1160
Modelling COVID-19 Vaccination in the UK: Impact of the Autumn 2022 and Spring 2023 Booster Campaigns Diana MendesSheeja Machira KrishnanJingyan Yang Original Research Open access 25 April 2024 Pages: 1127 - 1146
Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis Tetsuya MatsumotoAkira YuasaNaohiro Yonemoto Original Research Open access 25 April 2024 Pages: 1105 - 1125
Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK Alen MarijamNikki VroomHilde Vroling Original Research Open access 24 April 2024 Pages: 1083 - 1104
Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study Marta ColaneriCamilla GenoveseAndrea Gori Brief Report Open access 21 April 2024 Pages: 1147 - 1157
Underlying Neural Mechanisms of Cognitive Improvement in Fronto-striatal Response Inhibition in People Living with HIV Switching Off Efavirenz: A Randomized Controlled BOLD fMRI Trial Patrick G. A. OomenCharlotte S. HakkersStefan du Plessis Original Research Open access 20 April 2024 Pages: 1067 - 1082
Fungal Prosthetic Joint Infection: A Case Series and Review of the Literature Victoria StarnesJoan DugganCaitlyn Hollingshead Original Research Open access 13 April 2024 Pages: 1051 - 1065
Effect of Regdanvimab on Mortality in Patients Infected with SARS-CoV-2 Delta Variants: A Propensity Score-Matched Cohort Study Soyoon HwangNan Young LeeKi Tae Kwon Original Research Open access 12 April 2024 Pages: 1037 - 1050
Ritonavir: 25 Years’ Experience of Concomitant Medication Management. A Narrative Review Romina QuerciaGiovanni Di PerriMarta Boffito Review Open access 12 April 2024 Pages: 1005 - 1017
Systematic Review of Heel Puncture-Related Osteomyelitis of the Calcaneus in Newborn Infants Vidmi Taolam MartinIsmail Ahmed DhageyBin Yu Review Open access 08 April 2024 Pages: 991 - 1004
Structured Literature Review to Identify Human Papillomavirus’s Natural History Parameters for Dynamic Population Models of Vaccine Impacts Ibrahim DiakiteBruno MartinsElamin Elbasha Review Open access 08 April 2024 Pages: 965 - 990
Seroprevalence and Shifting Endemicities of Hepatitis A Virus Infection in Two Different Geographical Areas in the Philippines Josefina C. CarlosVinna Marie T. QuinonesAdriana Guzman-Holst Original Research Open access 05 April 2024 Pages: 1019 - 1035
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany Sebastian GruhnManuel BatramOliver Damm Original Research Open access 04 April 2024 Pages: 907 - 920
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study Stefan SchneiderGary BlickAlan Oglesby Original Research Open access 03 April 2024 Pages: 891 - 906
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses Paul BensonJennifer KuretskiAlan Oglesby Original Research Open access 03 April 2024 Pages: 875 - 889
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations Alexy InciarteLorena de la MoraJosep Mallolas Case Report Open access 03 April 2024 Pages: 647 - 658
Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections Yuan-Yuan LiYan ChenBin Du Original Research Open access 27 March 2024 Pages: 861 - 874
Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019 Aleksandra Polkowska-KramekElizabeth BegierGernot Rohde Original Research Open access 23 March 2024 Pages: 845 - 860
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States Daniel MolnarElizabeth M. LaDesmond Curran Original Research Open access 20 March 2024 Pages: 827 - 844
Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis Protocol Robin BruyndonckxAleksandra Polkowska-KramekElizabeth Begier Study Protocol Open access 18 March 2024 Pages: 953 - 963
Best Practices for Identifying Hospitalized Lower Respiratory Tract Infections Using Administrative Data: A Systematic Literature Review of Validation Studies Germaine HanquetChristian TheilackerElizabeth Begier Review Open access 18 March 2024 Pages: 921 - 940
Evaluating the Demand for Nucleic Acid Testing in Different Scenarios of COVID-19 Transmission: A Simulation Study Yu-Yuan WangWei-Wen ZhangMing-xia Jing Original Research Open access 18 March 2024 Pages: 813 - 826
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework Sushma KavikondalaKatrin HaeusslerEkkehard Beck Original Research Open access 18 March 2024 Pages: 779 - 811
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia Ru HanPeter San MartinDésirée A. M. van Oorschot Original Research Open access 17 March 2024 Pages: 761 - 778